Mary Seger

Pharmacokinetic‐pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis

William L. Macias, Jean-François Dhainaut, Sau Chi Betty Yan et al. · Clinical Pharmacology & Therapeutics · 2002 · 98 citations

Comparison of the Pharmacokinetics and Pharmacodynamics of LY2963016 Insulin Glargine and EU- and US-Approved Versions of Lantus Insulin Glargine in Healthy Subjects: Three Randomized Euglycemic Clamp Studies

Helle Linnebjerg, Eric Chen Quin Lam, Mary Seger et al. · Diabetes Care · 2015 · 95 citations

Recommendations for Systematic Statistical Computation of Immunogenicity Cut Points

Viswanath Devanarayan, Wendell C. Smith, Rocco L. Brunelle et al. · The AAPS Journal · 2017 · 89 citations

Vaccination, Statistical Computing, Immunophenotyping +5

Dose Response of Inhaled Dry-Powder Insulin and Dose Equivalence to Subcutaneous Insulin Lispro

Klaus Rave, Leszek Nosek, Amparo de la Peña et al. · Diabetes Care · 2005 · 75 citations · Full text

Effect of age on the pharmacokinetics of duloxetine in women

Michael Skinner, Han‐Yi Kuan, Andrej Skerjanec et al. · British Journal of Clinical Pharmacology · 2003 · 69 citations · Full text